Wells Fargo’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Buy |
56,705
+16,547
| +41% | +$158K | ﹤0.01% | 3731 |
|
|
2025
Q1 | $420K | Buy |
40,158
+1,404
| +4% | +$14.7K | ﹤0.01% | 3796 |
|
|
2024
Q4 | $913K | Buy |
38,754
+13,677
| +55% | +$322K | ﹤0.01% | 3329 |
|
|
2024
Q3 | $901K | Sell |
25,077
-983
| -4% | -$35.3K | ﹤0.01% | 3270 |
|
|
2024
Q2 | $920K | Buy |
26,060
+6,103
| +31% | +$215K | ﹤0.01% | 3233 |
|
|
2024
Q1 | $567K | Buy |
19,957
+6,928
| +53% | +$197K | ﹤0.01% | 3470 |
|
|
2023
Q4 | $173K | Sell |
13,029
-22,217
| -63% | -$295K | ﹤0.01% | 4157 |
|
|
2023
Q3 | $316K | Sell |
35,246
-1,070
| -3% | -$9.59K | ﹤0.01% | 3767 |
|
|
2023
Q2 | $409K | Buy |
36,316
+30,469
| +521% | +$343K | ﹤0.01% | 3888 |
|
|
2023
Q1 | $67.4K | Buy |
+5,847
| New | +$67.4K | ﹤0.01% | 4719 |
|
|
2022
Q4 | – | Sell |
-41
| Closed | -$1K | – | 7168 |
|
|
2022
Q3 | $1K | Sell |
41
-315
| -88% | -$7.68K | ﹤0.01% | 5984 |
|
|
2022
Q2 | $2K | Sell |
356
-1,017
| -74% | -$5.71K | ﹤0.01% | 6006 |
|
|
2022
Q1 | $13K | Sell |
1,373
-10,672
| -89% | -$101K | ﹤0.01% | 5820 |
|
|
2021
Q4 | $144K | Buy |
+12,045
| New | +$144K | ﹤0.01% | 5064 |
|
|
2021
Q3 | – | Sell |
-323
| Closed | -$7K | – | 6697 |
|
|
2021
Q2 | $7K | Sell |
323
-4,726
| -94% | -$102K | ﹤0.01% | 5898 |
|
|
2021
Q1 | $78K | Sell |
5,049
-2,340
| -32% | -$36.2K | ﹤0.01% | 5252 |
|
|
2020
Q4 | $155K | Buy |
+7,389
| New | +$155K | ﹤0.01% | 5041 |
|